Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is a 20% decrease from the number of companies cited in the previous year.
Of the nine citations issued, the most common citation was 'The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed'.
Most of the companies cited were involved in the Drugs sector.
All of the companies cited should take voluntary actions to correct their managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
AKI, Inc. | Drugs | 07/20/2023 | Sanitation--buildings not clean, free of infestation |
AKI, Inc. | Drugs | 07/20/2023 | Cleaning / Sanitizing / Maintenance |
AKI, Inc. | Drugs | 07/20/2023 | Packaging line inspection after use |
AKI, Inc. | Drugs | 07/20/2023 | Written records kept in individual logs |
Fertility Center, LLC | Biologics | 12/07/2023 | Personal information included in I.D. code |
Fertility Center, LLC | Biologics | 12/07/2023 | Name and personal info on accompanying records |
RWM Technologies, LLC | Drugs | 01/13/2023 | Procedures not in writing, fully followed |
RWM Technologies, LLC | Veterinary | 01/13/2023 | Procedures not in writing, fully followed |
SRI Healthcare, LLC | Devices | 01/12/2023 | Process control procedures, Lack of or inadequate procedures |